OTC Markets OTCPK - Delayed Quote USD

CBD Life Sciences Inc. (CBDL)

Compare
0.0005 0.0000 (0.00%)
As of 2:16 PM EST. Market Open.

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Ms. Lisa Anne Nelson CEO, President, CFO, Secretary, Treasurer & Director 120k -- 1967
Mr. Matthew McGee Chief Marketing Officer 60k -- 1999
Ms. Brianna Nelson Chief Product Developer & Director -- -- 1997

CBD Life Sciences Inc.

10855 N 116th Street
Suite 115
Scottsdale, AZ 85259
United States
480 410 6780 https://lbcbioscienceinc.com
Sector:?
Healthcare
Full Time Employees:?
3

Description

CBD Life Sciences Inc. engages in the development and marketing a line of cannabidiol based organic products. Its cannabidiol based organic products include hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, coffee, wine, skincare line, tablets, and a line of pet products. The company is based in Scottsdale, Arizona.

Corporate Governance

CBD Life Sciences Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

September 19, 2024 at 12:00 AM UTC

253G2: Reflects information that constitutes a substantive change from or addition to the information set forth in the last offering circular

September 6, 2024 at 12:00 AM UTC

1-A POS: Additional Forms

August 19, 2024 at 12:00 AM UTC

1-A POS: Additional Forms

June 24, 2024 at 12:00 AM UTC

253G1: Reflects information previously omitted from the offering circular in reliance on Rule 253(b)

June 18, 2024 at 12:00 AM UTC

1-A/A: Additional Forms

June 17, 2024 at 12:00 AM UTC

CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission

June 5, 2024 at 12:00 AM UTC

1-A/A: Additional Forms

May 2, 2024 at 12:00 AM UTC

1-A: Additional Forms

May 1, 2024 at 12:00 AM UTC

1-Z: Exit Report under Regulation A

January 8, 2024 at 12:00 AM UTC

1-U: Current Report pursuant to Regulation A

Related Tickers